Finally, the precise role of identified hub genes in AD requires additional elucidation both in vitro and in vivo. Further research is essential to determine whether CCR7, CXCL10, IRF7, MMP1, and RRM2 could be used as predictive biomarkers for the diagnosis and treatment of AD. This evidence concerns the gene CXCL10 and Alzheimer disease.